Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

Adalimumab can cause complete hair loss in rare cases.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

RDW can be a useful marker for inflammation in alopecia areata patients.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Abrocitinib may effectively treat stubborn alopecia universalis.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Alopecia areata incognito in children can be effectively treated with triamcinolone acetonide and supplements, leading to full hair regrowth.

The NIPAL4 mutation c.527C>A is common in Romanian patients with autosomal recessive congenital ichthyosis.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Etanercept may not prevent alopecia areata from coming back.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Both microneedling and injections are equally effective for treating alopecia areata.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Tofacitinib is an effective and safe treatment for alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Early intervention with JAK inhibitors may prevent alopecia areata progression.